 This research study uses Epstein-Barr virus EBV specific cytotoxic T lymphocytes CTLs. We want to see if we can grow special white blood cells, called T cells, that have been trained to kill EBV infected cells in the laboratory and see if these cells may help control the EBV infection when given back to the patient. 